chrisvoncsefalvay/vaers-outcomes huggingface dataset:
bilateral leg pain from his hips all the way down; bilateral leg pain from his hips all the way down; This is a spontaneous report from a contactable pharmacist (patient's wife). A 59-years-old male patient (reporter's husband) received BNT162B2 (Pfizer-BioNTech COVID-19 vaccine), via an unspecified route of administration on 18Apr2021 (Lot number and Expiry date was not reported) as dose 2, single for COVID-19 immunization. The patient's and concomitant medications were not reported. The patient previously received the first dose of bnt162b2 on 26Mar2021 for COVID-19 immunization. It was reported that towards the end of Jun2021, the patient started complaining of bilateral leg pain from his hips all the way down. The patient went to an urgent care. He went to the family physician and they ordered an ultrasound to check for deep vein thrombosis and abdominal aneurysm and it was negative. The pain was not going away and it was very severe. They ordered bloodwork on an unknown date and tested lyme disease but it was negative. The pain took 2 weeks to go away. The patient had to take Tylenol and Advil around the clock spaced out for two weeks. The reporter believed that it is related to the Pfizer Covid vaccine. This was out of character for the patient. They have not been able to diagnose it. This happened after the second shot. The leg pain went away on Jul2021 (reported as 'around 10Jul2021'). The patient recovered but did not specify if completely or with lasting effects. The patient had other inflammatory markers done that came back negative. The events were reported with a seriousness of disability. The events recovered on an unknown date in Jul2021.   Information about Lot/batch number has been requested; Sender's Comments: A causal association between BNT162B2 and the reported events cannot be excluded based on temporal relationship. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to RAs, Ethics Committees, and Investigators, as appropriate.
shingles; This spontaneous report has been received from a lawyer regarding a case in litigation, concerning a male patient of unknown age. His medical history, concurrent conditions and concomitant medications were not provided. On or about 10-APR-2008, the patient was vaccinated with zoster vaccine live (ZOSTAVAX) (strength, lot #, expiration date, dosage, anatomical location and route of administration were not provided), as prescribed and/or administered by a healthcare provider, for the long-term prevention of shingles and/or zoster-related conditions. Subsequent to vaccination, he was treated by a physician for shingles (herpes zoster). As a direct and proximate result of zoster vaccine live (ZOSTAVAX) use, the patient had and will continue suffer ongoing injuries, including but not limited to: mental and physical pain and suffering; medical care and treatment for those injuries; significant medical and related expenses as a result of those injuries, including but not limited to medical losses and costs include care for hospitalization, physician care, monitoring, treatment, medications, and supplies; diminished capacity for the enjoyment of life; diminished quality of life; increased risk of premature death, aggravation of preexisting conditions and activation of latent conditions; and other losses and damages; and will continue to suffer such losses, and damages in the future. The outcome for herpes zoster was unknown.
Fatigue. Impaired cognition. Chills. GI upset. Headaches. Muscle aches.
Tiredness, headache, chills, muscle pain, headache/migraine, nausea, injection site pain  starting 1/27/2021 and persistent
Information has been received from a nurse referring to an unspecified number of patients of unknown gender and age. No concurrent or historical conditions were reported. On unknown dates, the patients were vaccinated with doses of ROTATEQ orally (strength, dose, lot# and expiration date unknown), which were improperly stored. No adverse experiences had been reported. This is one of several reports received from the same reporter. Additional information has been requested.
After 15 minutes of receiving vaccine client complained of itching all over body. 25 mg of Benadryl administered. Patient stayed extra 15 minutes  in observation.  No complaints of symptoms.
5 hours after injections: pain in right arm, axilla, neck, head. SOB. Near syncope. 1 day after injection: near syncope, headache, dizziness.
Pt reported a very large red, hot and inflamed area at the injection site.  Pt is also running fever.  Pt was also given the influenza vaccine at the same time in a different arm.
p/receiving a dose of Td, pt exp tenderness & swelling @ inject site; p/2 wks, a large knot that is red & hot to the touch, still remains;
Symptoms   Fatigue, shortness of breath, can?t catch my breath since yesterday,  feels like I have something like  lemon-size stuck in between my chest and throat that wont move and is blocking air from flowing, and like i want to burp so bad but can?t.  unexplainable desire to just sit down, no pain in legs, but shaking and weak knees. Lower ab pain, under belly button, as if i was carrying a watermelon, hunched back. My mood is normal-happy.
patient called today and states that she started having  swelling in both feet 1 week after her 1st dose of vaccine.
Patient experienced soreness and extreme redness in area of and area surrounding where the vaccine had been given (upper right shoulder)  The vaccine was a Pneunomia booster shot.  I had received one in 2001.
Headache, Fever, COLD HILLS, FATIGUE, SORE ARM Narrative:  Other Relevant History:
An allergic reaction that required a visit to the Emergency Room. Shots were given at the hospital, so their response to treatment was swift. Given an IV of antihistamines, steroids, and something else. Given a CAT scan to ensure swelling was subsiding. Within 10 minutes after the second shot, my neck had a bulge the size of a softball.  This was day one.  As I type this message, it is now 22 days since that injection and I still have large swelling of my left lymph nodes on my neck and around my left shoulder blade causing me pain.
Dose administered to 10 patients after more than 30 days of storage in the fridge; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Dose administered to 10 patients after more than 30 days of storage in the fridge) in a 35-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 033H21A) for COVID-19 vaccination.     No Medical History information was reported.    On 11-Feb-2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 11-Feb-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Dose administered to 10 patients after more than 30 days of storage in the fridge). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Dose administered to 10 patients after more than 30 days of storage in the fridge) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No Concomitant medications were reported. No Treatment medications were reported.
Lost her right foot from foot drop; Tingling in her leg; Nerve damage in her right leg; This is a spontaneous report from a contactable consumer. A 68-year-old female patient received pneumococcal 13-valent conjugate vaccine (diphtheria crm197 protein) (PREVNAR 13 [also reported as Prevnar 23]; Lot number: N010106, Expiry Date: 15Nov2018), intramuscular on the left arm in Aug2017 at a single dose for immunization. The patient had no relevant medical history and no concomitant medications. The patient stated that the doctor that gave her the vaccine was her family doctor. She started to have an adverse reaction two weeks after she received the vaccine on an unspecified date in 2017. She received the vaccine in late Aug2017. She received all the doctors reports after he passed away. Her reaction had not improved, but it hasn't gotten worse either. She has not had a vaccine since. She received it at the doctor's office in her left arm. When they gave the vaccine, they took the wrapper from around the vaccine and put it on her chart.  The patient stated that she will never get it again. Within two weeks of the vaccine, on an unspecified date in 2017, she had tingling in her leg. Within 3 months of the vaccine, she lost her right foot from foot drop. She had nerve damage in her right leg. That vaccine was all she had gotten. She had been tested for everything, and nothing showed up on anything. There had been no progression in two years. She went to a physical with her doctor, who had been her doctor for 30 years. She had always refused the flu shot and the shingles shot, but he sprung the pneumococcal 13-valent conjugate vaccine on her. If she had time to think about it , she would have said no. They have done tests and tried to figure out what was going on. Her daughter in law asked if she had gotten any shots around that time, and that was when they realized she had had pneumococcal 13-valent conjugate vaccine two weeks before. Otherwise, she was a healthy woman. Outcome of the event tingling in her leg was not recovered, while for the events lost her right foot from foot drop and nerve damage in her right leg was unknown.
rash on arm right at injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE RASH (rash on arm right at injection site) in a 56-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 00JAZ1A) for COVID-19 vaccination.     No medical history was provided by the reporter.     On 10-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Mar-2021, the patient experienced VACCINATION SITE RASH (rash on arm right at injection site). The patient was treated with ALPRAZOLAM at an unspecified dose and frequency; PROMETHAZINE at an unspecified dose and frequency; TRAMADOL at an unspecified dose and frequency and AZITHROMYCIN at an unspecified dose and frequency. On 30-Mar-2021, VACCINATION SITE RASH (rash on arm right at injection site) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
PATIENT REPORTED THIS ON 03/01/2021- WITHING 5 MINUTES OF IMMUNIZATION HE HAD PUFFED UP UPPER LIP , A LITTLE SWELLING IN THROAT AND LITTLE DIFFICULTY SWALLOWING. IT LASTED ABOUT 15 MINUTES AND THEN PASSED.  Patient also stated that this reaction was similar to  a reaction he had previously when he had a banana at age 21. now he is 72. Patient spoke to his Doctor on 03/01/2021. Doctor advised him to take Benadryl 25 at 8 am and 6 hours later after the second dose of covid-19.  We advised him to get his second dose at a hospital or doctor's office if possible.
Patient did not show symptoms of an adverse reaction. The MMR vaccines expired on 01/08/2022 and the vaccine was administered  to the patient on 01/18/2022, so it was 10 days expired.
Immediate pain and Nausea when vaccine was administered.  Severe arm discomfort and swelling for a few days after vaccine administration. After a few weeks the pain did not go away and my range of motion in my left arm and shoulder were very limited. Could not lift arm above my head. I was unable to sleep comfortably and was taking OTC meds for pain as well as topical meds. I made an appt. 4/6/21 with my PCP when the pain was not going away.  She prescribed me Prednisone 10 mg po tabs -- 4 tabs once daily x 1 day then 3 tabs once daily x 2 days then 2 tabs once daily x 2 days then 1 tab once daily x 1 day.  She suggested I needed to see an orthopedic Dr. and have a musculoskeletal Ultrasound. She suspected SIRVA ( Shoulder Injury Related to Vaccine Administration) I made an appt with the orthopedic dr. on 5/18/21.  He also suggested that I had bursitis from my vaccine given intrabursal and not intramuscular. I had an ultrasound and also did Physical Therapy for a few weeks. If the injury does not improve I would need a cortisone steroid shot.
Painful swelling on site of injection, Hot at touch. Area about 3-4 Inches of injection site.
sore arm from the third for about three hours; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (sore arm from the third for about three hours) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.    Co-suspect product included non-company product PANCREATIN (CREON) for Pancreatic exocrine insufficiency.    No Medical History information was reported.   On an unknown date, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form On an unknown date, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form and first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. and PANCREATIN (CREON) (unknown route) at an unspecified dose. On an unknown date, the patient experienced PAIN IN EXTREMITY (sore arm from the third for about three hours). At the time of the report, PAIN IN EXTREMITY (sore arm from the third for about three hours) outcome was unknown.            No concomitant medications were reported. It was unknown if patient was enrolled in a COVID-19 Vaccine Trial. No treatment medications were reported. This case was identified as part of a retrospective clean-up activity where certain emails received in the Moderna
Pt developed symptoms of a pulmonary embolism (4/3/21) 10 days after 1st vaccine (3/24/21) Presented to hospital 4/12 with progressive symptoms. Diagnosed and started on blood thinners with tpa administration for severe right heart strain followed by discharge home.
Chills; Body Aches; Headache; Fever; This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (Chills), MYALGIA (Body Aches), HEADACHE (Headache) and PYREXIA (Fever) in a 79-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031M20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 14-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Feb-2021, the patient experienced CHILLS (Chills), MYALGIA (Body Aches), HEADACHE (Headache) and PYREXIA (Fever). At the time of the report, CHILLS (Chills), MYALGIA (Body Aches), HEADACHE (Headache) and PYREXIA (Fever) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant information provided. No treatment information provided.
48 post vac., localized reaction raised, red and hot to touch. 72 hrs. urgent care. Signs of cellulitis. Script for antibiotic and steroid. Mon. stayed home from work. Home early on Tues. minimal swelling.
Within a couple minutes of receiving shot, felt pain at injection site that traveled up arm into neck. Heart rate went up to 122bpm. Left side of face felt puffy and numb. Left side of mouth and tongue were tingling. Reported this to vaccine giver, he had me wait about half an hour before suggesting Benadryl. Half an hour after 25mg Benadryl, symptoms were almost completely resolved.  The next day (3/14) I felt tired. The day after (3/15) I felt hot and my skin was flushed. I was not running a fever. I generally felt unwell that day. I felt better by the time I woke up on 3/16. I also had a bad/metallic taste in my mouth through 3/21, which has resolved.  My nurse practitioner suggested that I take Benadryl before I receive my second vaccine dose on 4/3/21.
Information has been received from a physician concerning a 13 year old male patient who was vaccinated with the first and second dose of MMR II respectively on 25-FEB-1998 and on 20-FEB-2000. On 10-NOV-2009 the patient developed afebrile mumps. The patient was diagnosed on 7-DEC-2009.  The patient's fever count was 37 and his parotitis was on the left side; count was 45. On 07-DEC-2009 the patient's, serum immunoglobulin G (IgG) was 8.12 and serum amylase was 397. The outcome of the patient was not reported. Follow up information was received. It was reported that on 24-DEC-2009 the patient developed afebrile mumps. The patient was diagnosed on 25-DEC-2009. The patient was afebrile. The patient was reported to have exposure to others with mumps. At the time of this report, the patient's outcome was unknown. Additional information has been requested.
After I took the vaccine my arm got sore and red. Wednesday night I got a very bad sinus headache, the right side of my head (neck & throat) were super sore. I could barely hold my head up it hurt so bad. I was sick up until yesterday I started to feel somewhat better. My right ear is stopped up and I have had some dizziness. I was also burning up. I went to urgent care yesterday and the prescribed me  antibiotics, they also told me to take Benadryl and ibuprofen.
She had erythema at the site of injection with soreness starting the following day, it has progressed  and over the past couple of days the injection site has become indurated swollen, hot and the area of erythema has increased from the size of a quarter (description by patient) to now 5x4 cm at day 9 s/p injection
Narrative: Patient reported experiencing nausea/vomiting shortly after receiving first dose of Moderna Covid vaccine (~1-2 hours post administration). Patient also reported experiencing slight swelling of the tongue. They were instructed to report to local ED for further evaluation. Parent presented to OSH ED, Per administered. Angioedema of the left lateral tongue was observed-No respiratory distress was noted. Patient was also taking lisinopril at the time and this could not be ruled out as potential cause/contributing factor. Patient was instructed to stop lisinopril, and after a period of observation, discharged home.
no adverse effects reported; patient was vaccinated with improperly stored MMR II; This spontaneous report has been received from a medical assistant, concerning a patient of unknown age and gender. The patient's medical history, concurrent conditions and concomitant medications were not provided.  On 10-JAN-2019, the patient was vaccinated with improperly stored dose of measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live(M-M-R II) (albumin status rHA) one dose, lot # R019391 with expiration date 05-JUL-2020 (frequency, route and anatomical location were not provided) which was reconstituted with sterile diluent (dose, frequency, route, lot number and expiration date were not provided) for prophylaxis. No adverse effects reported.  The temperature and time frame were unknown by reporter. There was previously temperature excursions and digital data logger was involved.  This is one of several reports received from the same reporter.; Sender's Comments:  US-009507513-1906USA011469: US-009507513-1907USA010301: US-009507513-1907USA010302: US-009507513-1907USA010303: US-009507513-1907USA010304: US-009507513-1907USA010305: US-009507513-1907USA010306: US-009507513-1907USA010307: US-009507513-1907USA010308: US-009507513-1907USA010309: US-009507513-1907USA010310: US-009507513-1907USA010311: US-009507513-1907USA010312: US-009507513-1907USA010313: US-009507513-1907USA010314: US-009507513-1907USA010315: US-009507513-1907USA010316: US-009507513-1907USA010317: US-009507513-1907USA010318: US-009507513-1907USA010319: US-009507513-1907USA010320: US-009507513-1907USA010321: US-009507513-1907USA010322: US-009507513-1907USA010323: US-009507513-1907USA010324: US-009507513-1907USA010325: US-009507513-1907USA010326: US-009507513-1907USA010327: US-009507513-1907USA010328: US-009507513-1907USA010329: US-009507513-1907USA010330: US-009507513-1907USA010331: US-009507513-1907USA010332: US-009507513-1907USA010333: US-009507513-1907USA010334: US-009507513-1907USA010335: US-009507513-1907USA010336: US-009507513-1907USA010337: US-009507513-1907USA010338: US-009507513-1907USA010339: US-009507513-1907USA010340: US-009507513-1907USA010342: US-009507513-1907USA010343: US-009507513-1907USA010344: US-009507513-1907USA010345: US-009507513-1907USA010346: US-009507513-1907USA010347: US-009507513-1907USA010348: US-009507513-1907USA010349: US-009507513-1907USA010350: US-009507513-1907USA010351: US-009507513-1907USA010352: US-009507513-1907USA010353: US-009507513-1907USA010354: US-009507513-1907USA010355: US-009507513-1907USA010356: US-009507513-1907USA010357: US-009507513-1907USA010358: US-009507513-1907USA010359: US-009507513-1907USA010360: US-009507513-1907USA010361: US-009507513-1907USA010362: US-009507513-1907USA010363: US-009507513-1907USA010364: US-009507513-1907USA010365: US-009507513-1907USA010366: US-009507513-1907USA010367: US-009507513-1907USA010368: US-009507513-1907USA010369: US-009507513-1907USA010370: US-009507513-1907USA010371: US-009507513-1907USA010372: US-009507513-1907USA010373:
painful swelling in left breast / nipple area - lasted about 4-5 days.   subsequent 3 doctor visits showing swelling in lymph nodes.   Consultation, Mammograms' (twice) and 3d imaging.
Pt developed severe systemic rxn, feb illness w/coagulopathy & thrombocytopenia, hepatitis, & mild renal insufficiency, fever, shaking chills, myalgias, h/a, & mild SOB;On exam diaphoretic & mod distress; periorital & face edema;
pt. presented to the ED at clinic on 17 June. She reported SOB and slurred speech since last night at 2100. as well as abd, flank and back pain.  COVID vaccine noted in provider note and temporarily related. Stroke ruled out but possible CVA-TIA.  Severe HTN also noted. Still admitted
The first day at night woke up with night sweats and fatigue. Second-day headache and have a rash on the upper front part of my body and the upper part of my body on my back.
Extreme arthritis pain in my body, including all areas. It's much worse in the mornings after I've not been moving all night. Also frequent diarrhea (1-3x / week) for no apparent reason.
This is a spontaneous report received from a contactable consumer, the patient. A 76-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6202) via an unspecified route of administration in the left arm on 16Mar2021 at 11:30 (at the age of 76-years-old) as a single dose for COVID-19 immunisation. Medical history of the patient included high blood pressure. Concomitant medications were not reported. The patient was allergic to latex, sulfonamide, cipro and eggs. The patient did not receive any other vaccine within 4 weeks prior to the COVID vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 21Mar2021,5 days after the vaccination, the patient had shingles . The patient applied cortizone as treatment for the adverse event. The event resulted in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the event shingles was not recovered at the time of this report.   No follow-up attempts are needed. No further information is expected.